Therapy Areas: Respiratory
25 November 2020 - - Enrolment of 327 patients with mild-to-moderate symptoms of SARS-CoV-2 infection has completed in the global Phase II clinical trial of CT-P59, an anti-COVID-19 monoclonal antibod...
25 November 2020 - - The US Food and Drug Administration has granted an Emergency Use Authorization amendment that expands the installed base of RT-PCR platforms that can process US-based DNA manufact...
25 November 2020 - Integral Molecular, a company discovering antibodies against multipass membrane proteins, has launched fully optimised, high-affinity lead monoclonal antibodies against Claudin 18.2...
23 November 2020 - - US-based biotherapeutics company HiFiBiO Therapeutics has forged a partnership with Russian pharmaceutical company Pharmsynthez PJSC (MOEX: LIFE), and Shemyakin and Ovchinnikov In...
23 November 2020 - - US-based synthetic biology and genomics company Twist Bioscience Corp. (NASDAQ: TWST) has released preclinical data for three of its proprietary antibodies against the S1 protein ...
23 November 2020 - - A study published in the American Journal of Emergency Medicine this month reports on an assessment tool developed by California, US-based healthcare provider Kaiser Permanente�...
Related Headlines